⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OBIO News
Orchestra BioMed Holdings, Inc. Ordinary Shares
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OBIO
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
globenewswire.com
OBIO
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
globenewswire.com
OBIO
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
globenewswire.com
OBIO
MDT
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
globenewswire.com
OBIO
LGND
MDT
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
globenewswire.com
OBIO
MDT
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
globenewswire.com
OBIO
MDT
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
globenewswire.com
OBIO
MDT
OBI Pharma、AACR 2026年次総会で10件のポスター発表を開催
accessnewswire.com
OBIO
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies
accessnewswire.com
OBIO